Drug intelligence / Profile preview

UMC119-06-05 + hyaluronic acid

Development stage: Unknown
Lead developer: Meribank Biotech
Modality: Cell Therapies
Administration: Intraarticular

Overview

UMC119-06-05 + hyaluronic acid is an investigational combination therapy consisting of allogeneic human umbilical cord-derived mesenchymal stem cells (UC-MSCs) and a hyaluronic acid carrier. Developed by U-Stem Biomedical, the treatment is intended for patients with knee osteoarthritis. The UC-MSCs (UMC119-06-05) exert therapeutic effects through the secretion of trophic factors that promote cartilage repair and suppress synovial inflammation. Hyaluronic acid acts as a lubricant and a structural scaffold, enhancing the retention and biological activity of the injected stem cells within the intra-articular space.

Other names: UMC119-06-05 plus hyaluronic acidUMC-119-06-05 plus hyaluronic acidUMC 119-06-05 plus hyaluronic acidhuman umbilical cord-derived mesenchymal stem cells + hyaluronic acidUC-MSCs + HA

Beyond the preview

Go deeper on UMC119-06-05 + hyaluronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UMC119-06-05 + hyaluronic acid.

Explore the full profile